# Statin Therapy in Heart Failure: Potential Mechanisms of Benefit

> **NCT00233480** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 27 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** atorvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00233480
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233480, "Statin Therapy in Heart Failure: Potential Mechanisms of Benefit". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00233480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*